AAM To OMB: Quality Metrics Guide Violates Laws, Against Program's Purpose

March 30, 2017 at 7:37 PM

The Association for Accessible Medicines is calling on both FDA and the White House to pull FDA's November 2016 draft guidance on quality metric submissions, arguing the guide runs counter to a slew of federal laws and agency regulations.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.